TD Cowen adjusted its price target for ADP (NASDAQ: ADP) shares, increasing it marginally from $290.00 to $294.00, while maintaining a Hold rating on the stock. The price target revision reflects the ...

In a report released today, Marc Bianchi from TD Cowen maintained a Hold rating on Liberty Oilfield Services (LBRT – Research Report), with a ...

TD Cowen analysts increased the price target for Synchrony Financial (NYSE:SYF) shares to $80.00, up from the previous $75.00, while reiterating a Buy rating. The adjustment follows Synchrony ...

On Tuesday, TD Cowen maintained a positive outlook on Planet Fitness (NYSE:PLNT) shares, reiterating a Buy rating with a steady price target of $120.00. The stock, which has gained an impressive ...

"ST is a leader in power semis and [microcontroller], with its manufacturing network a long-term advantage, but near-term revenue/ margins are likely to remain muted," TD Cowen analyst Joshua ...

On Monday, TD Cowen analyst Marc Bianchi upgraded Linde stock (NASDAQ:NYSE:LIN) from Hold to Buy, setting a new price target of $515, up from the previous $480. The adjustment reflects a positive ...

Investing.com -- TD Cowen downgraded STMicroelectronics (NYSE:STM) stock to Hold, citing increased cyclical headwinds in the semiconductor industry amid downstream inventory pressures. The firm ...

Investing.com -- TD Cowen downgraded STMicroelectronics (NYSE:STM) stock to Hold, citing increased cyclical headwinds in the semiconductor industry amid downstream inventory pressures. The firm also ...

In a report released on January 6, Helane Becker from TD Cowen maintained a Hold rating ... Becker is a 5-star analyst with an average return of 14.4% and a 65.33% success rate.

Sana Biotechnology (NASDAQ:SANA – Get Free Report) was upgraded by investment analysts at TD Cowen from a “hold ... One equities research analyst has rated the stock with a hold rating ...

TD Cowen analyst Joshua Jennings initiated coverage of Anteris Technologies (AVR) with a Buy rating and $15 price target Anteris has developed DurAVR, a first-in-class biomimetic transcatheter ...